Vous n'êtes pas identifié (connexion)

Centre de recherche

CARRIÈRES

Infirmière de recherche

Louis Lacombe

Liste des opportunités >

BOTTIN

Mariana Baz Etchebarne

Formation
à venir

Aucune offre active

Autres opportunités de carrière
Axe principal
Maladies infectieuses et immunitaires
Adresse(s)
Centre Hospitalier de l'Université Laval (CHUL)
2705, boulevard Laurier
R-0-709
Québec (Québec)
CANADA G1V 4G2

Téléphone(s)
+1 418-525-4444, poste 48281
Télécopieur(s)
+1 418-654-2715
Courriel(s)
mariana.baz@crchudequebec.ulaval.ca

Projet(s) de recherche actif(s)

Aucun projet de recherche à afficher

Publications récentes (voir toutes les publications de ce chercheur)

Baz M, Goyette N, Griffin BD, Kobinger GP, Boivin G. In vitro susceptibility of geographically and temporally distinct zika viruses to favipiravir and ribavirin. Antiviral therapy,  2017. Epub
Retamal M, Abed Y, Rheaume C, Baz M, Boivin G. In vitro and in vivo evidence of a potential A(H1N1)pdm09 antigenic drift mediated by escape mutations in the haemagglutinin Sa antigenic site. The Journal of general virology,  2017. 98: 1224-1231
Boonnak K, Matsuoka Y, Wang W, Suguitan AL Jr, Chen Z, Paskel M, Baz M, Moore I, Jin H, Subbarao K. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses. Journal of virology,  2017. Epub
Stephen P, Baz M, Boivin G, Lin SX. Structural Insight into NS5 of Zika Virus Leading to the Discovery of MTase Inhibitors. Journal of the American Chemical Society,  2016. 138: 16212-16215
Baz M, Subbarao K. An addition to treatment options for avian influenza A H5N1? The Lancet infectious diseases,  2015. 15: 251-3
Baz M, Paskel M, Matsuoka Y, Zengel J, Cheng X, Treanor JJ, Jin H, Subbarao K. A live attenuated equine H3N8 influenza vaccine is highly immunogenic and efficacious in mice and ferrets. Journal of virology,  2015. 89: 1652-9
Baz M, Paskel M, Matsuoka Y, Zengel JR, Cheng X, Treanor JJ, Jin H, Subbarao K. A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and Ferrets. Journal of virology,  2015. 89: 6907-17
Baz M, Boonnak K, Paskel M, Santos C, Powell T, Townsend A, Subbarao K. Nonreplicating influenza A virus vaccines confer broad protection against lethal challenge. mBio,  2015. 6: e01487-15
Pizzorno A, Abed Y, Plante PL, Carbonneau J, Baz M, Hamelin ME, Corbeil J, Boivin G. Evolution of oseltamivir resistance mutations in Influenza A(H1N1) and A(H3N2) viruses during selection in experimentally infected mice. Antimicrobial agents and chemotherapy,  2014. 58: 6398-405
Chen Z, Baz M, Lu J, Paskel M, Santos C, Subbarao K, Jin H, Matsuoka Y. Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets. Journal of virology,  2014. 88: 7016-23
© 2017 Tous droits réservés Centre de recherche du CHU de Québec